Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 June 2007

Arch Dis Child. Published Online First: 26 October 2006. doi:10.1136/adc.2006.100065
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

Original articles

Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial

Nicola S Gittins 1, Yan L Hunter-Blair 2, John Matthews 3 and Malcolm G Coulthard 1*

1 Royal Victoria Infirmary, United Kingdom
2 Newcastle General Hospital, United Kingdom
3 University of Newcastle upon Tyne, United Kingdom

* To whom correspondence should be addressed. E-mail: malcolm.coulthard{at}nuth.nhs.uk.

Accepted 18 October 2006


Abstract

Objectives: To determine whether the tissue plasminogen activator, alteplase, is more effective than heparin in preventing blood clots developing in children’s haemodialysis central lines between dialysis sessions.

Design: A prospective double-blind, within- patient multiperiod cross-over controlled trial of instilling a ‘lock’ of either heparin 5,000 units/ml or alteplase 1 mg/ml into the central lines of 2 children haemodialysed twice weekly, and 7 dialysed thrice weekly, over 10 weeks.

Setting: A UK paediatric nephrology unit.

Main outcome measures: Weight of blood clot aspirated from the line at the start of the next dialysis session.

Results: The odds of a clot forming was 2.4 times greater with heparin than alteplase (CI=1.4,4.0; P=0.001), and when present they were 1.9 times heavier (31 vs 15 mg; CI=1.5,2.4; p<0.0005). There was no effect of inter-dialytic interval. One child required an alteplase infusion to clear a blocked line following a heparin lock. We subsequently changed our routine locks from heparin to alteplase. Comparing the year before and after that change, the incidence of blocked lines requiring an alteplase or urokinase infusion fell from 2.7 to 1.2 per child (P<0.03), and the need for surgical replacements from 0.7 to nil (P<0.02).

Conclusion: Alteplase is significantly more effective than heparin in preventing clot formation in central haemodialysis lines. This reduces morbidity and improves preservation of central venous access. It is more expensive, though relatively economic if packaged into syringes and stored frozen until needed, but reduces the costs of unblocking or replacing clotted lines.

Keywords: alteplase, central venous lines, haemodialysis, heparin, thrombus


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Atoms
Howard Bauchner
Arch. Dis. Child. 2007 92: 471. [Extract] [Full Text] [PDF]

A brief digest of the June issue
Arch. Dis. Child. 2007 92: e6. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Coulthard, M. G, Skinner, R. (2007). Should paediatric central lines be aspirated before use?. Arch. Dis. Child. 92: 517-518 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs